Tracking
Tracking tools surface the metrics that move during research peptide protocols — body composition shifts on GH-secretagogue and GLP-1 cycles, blood glucose changes during GLP-1 dose escalation, and lean-mass trajectory on recomp protocols. The 8-electrode body composition scale and the Bayer/Ascensia CONTOUR NEXT glucose meter are the two community sources reach for first.
Renpho 8-Electrode Smart Body Composition Scale
8-electrode model is meaningfully more accurate than standard 4-electrode scales. Tracks body fat %, lean mass, water weight — body comp shifts on GLP-1 and GH peptides often appear before scale weight does.
View on Amazon →
CONTOUR NEXT GEN Glucose Meter All-In-One Kit
Ascensia's CONTOUR NEXT GEN — the most clinically-validated home glucose meter. Includes 20 test strips + lancing device. Tracks the blood-sugar response GLP-1 users care about, especially during dose escalation.
View on Amazon →Common questions
Why an 8-electrode scale instead of standard?+
8-electrode scales pass current through hands AND feet, generating segmental impedance data (per-limb and per-region body composition) that 4-electrode foot-only scales can't. Research and community sources cite this as meaningfully more accurate for lean-mass and body-fat tracking, especially during peptide protocols where small composition shifts are the metric of interest.
Do GLP-1 users need a glucose meter?+
GLP-1 protocols (semaglutide, tirzepatide, retatrutide) primarily affect glycemic control. Community sources cite tracking fasting glucose during dose escalation as a way to verify protocol response and identify hypoglycemia risk early. The meter is not a substitute for clinical bloodwork (HbA1c, fasting insulin) but it's the daily-tracking layer.